These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23217529)
1. Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home. Reardon G; Pandya N; Nutescu EA; Lamori J; Damaraju CV; Schein J; Bookhart BK Am J Geriatr Pharmacother; 2012 Dec; 10(6):361-72. PubMed ID: 23217529 [TBL] [Abstract][Full Text] [Related]
2. Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation. Patel AA; Reardon G; Nelson WW; Philpot T; Neidecker MV Clin Ther; 2013 Nov; 35(11):1794-804. PubMed ID: 24139051 [TBL] [Abstract][Full Text] [Related]
3. Incidence of venous thromboembolism in nursing home residents. Reardon G; Pandya N; Nutescu EA; Lamori J; Damaraju CV; Schein J; Bookhart B J Am Med Dir Assoc; 2013 Aug; 14(8):578-84. PubMed ID: 23499170 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study. Rahme E; Feugère G; Sirois C; Weicker S; Ramos E Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095 [TBL] [Abstract][Full Text] [Related]
5. Warfarin use in nursing home residents: results from the 2004 national nursing home survey. Ghaswalla PK; Harpe SE; Slattum PW Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690 [TBL] [Abstract][Full Text] [Related]
6. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis. Xie L; Liu X; Phatak H; Mardekian J; Tan W; Baser O; Ramacciotti E Am J Ther; 2016; 23(6):e1744-e1753. PubMed ID: 26214203 [TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data. Menzin J; Preblick R; Friedman M; Menzin J; Frean M; Jacqueline Kwong W Hosp Pract (1995); 2014 Oct; 42(4):59-74. PubMed ID: 25502130 [TBL] [Abstract][Full Text] [Related]
8. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S; Bennett D; Smith DJ Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933 [TBL] [Abstract][Full Text] [Related]
9. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC; J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561 [TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients. Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079 [TBL] [Abstract][Full Text] [Related]
11. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575 [TBL] [Abstract][Full Text] [Related]
12. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study. Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073 [TBL] [Abstract][Full Text] [Related]
13. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice. Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013 [TBL] [Abstract][Full Text] [Related]
14. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes. Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533 [TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in lymphoma: how effectively are we treating patients? Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801 [TBL] [Abstract][Full Text] [Related]
16. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia. Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360 [TBL] [Abstract][Full Text] [Related]
17. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033 [TBL] [Abstract][Full Text] [Related]
18. [The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism]. Yang P; Wu QH; Luo XY; Kou L; Chen Z; Zhang YY; Zhou H Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1762-5. PubMed ID: 19862981 [TBL] [Abstract][Full Text] [Related]
19. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism. Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556 [TBL] [Abstract][Full Text] [Related]
20. National patterns of warfarin use in atrial fibrillation. Stafford RS; Singer DE Arch Intern Med; 1996 Dec 9-23; 156(22):2537-41. PubMed ID: 8951296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]